Drugs
nivolumab
Photo taken from primewomen.com

Chemotherapy with adjuvant nivolumab versus placebo for GEJ cancer

Syed A. Ahmad, Chief of Surgical Oncology at The University of Cincinnati, made the following post on X:

“Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5)⁦ .”

Additional information.
Source: Syed A. Ahmad/X

 

 

 

cancer chemotherapy gastric cancer gastro-oesophageal junction cancer Hyun Cheol Chung Jen-Shi Chen Jiafu Ji Jong Gwang Kim Keun Won Ryu Li-Tzong Chen Li-Yuan Bai lymph-node dissection Masanori Terashima Min-Hee Ryu Mitsuru Sasako Narikazu Boku nivolumab Norimasa Fukushima OncoDaily Oncology Shinichi Sakuramoto Shunsuke Hagihara Sun Young Rha Syed A. Ahmad Ta-Sen Yeh Tae Yong Kim Takanobu Yamada Takashi Nakada Takeshi Omori The University of Cincinnati Yasunori Nishida Yoon-Koo Kang Yoshinori Hirashima Young Woo Kim